表 2. Comparison of the dose of sufentanil among the three groups at different time points (
).
三组患者各时点使用舒芬太尼剂量比较(
)
| Group | n | T1/µg | T2/µg | T3/µg | T4/µg | T5/µg |
| Control | 43 | 0.18±0.02 | 6.3±0.8 | 12.9±1.4 | 24.8±2.6 | 49.2±5.1 |
| R | 43 | 0.19±0.02 | 6.5±0.8 | 13.2±1.5 | 25.2±2.8 | 49.8±5.2 |
| RD | 43 | 0.19±0.02 | 6.4±0.7 | 13.7±1.6 | 25.8±2.8 | 50.6±5.2 |